Samsara Bio Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $173 Million distributed in 42 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Scholar Rock Holding Corp with a value of $54.4M, Arcellx, Inc. with a value of $29.5M, Nkarta, Inc. with a value of $17M, Eliem Therapeutics, Inc. with a value of $13.3M, and Rhythm Pharmaceuticals, Inc. with a value of $9.04M.
Examining the 13F form we can see an decrease of $21.9M in the current position value, from $194M to 173M.
Samsara Bio Capital, LLC is based out at Palo Alto, CA
Below you can find more details about Samsara Bio Capital, LLC portfolio as well as his latest detailed transactions.
